FDA Clears Scaida AI Tool to Speed Intracranial Bleed Triage
mlHealth 360 has received U.S. FDA 510(k) clearance for Scaida BrainCT-ICH, the first Canada-developed AI-powered triage solution designed to...
Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
mlHealth 360 has received U.S. FDA 510(k) clearance for Scaida BrainCT-ICH, the first Canada-developed AI-powered triage solution designed to...
